Mancini Anthony sold RVMD

September 10, 2026 · Form 4 insider transaction

Mancini Anthony sold 300 shares of Revolution Medicines, Inc. at $207.17 per share, a transaction worth $62.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
300
Price
$207.17
Total value
$62.2K
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 10, 2026
Filing dateSeptember 14, 2026
Shares owned after43,890
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026.; The transaction was executed in multiple trades at prices ranging from $207.12 to $207.28, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.; Includes 43,700 restricted stock units.

View the original Form 4 on SEC EDGAR